What happened to the coxibs on the way to the cardiologist?

被引:7
作者
Alberts, DS [1 ]
Potter, JD
Martinez, ME
Hess, LM
Stopeck, A
Lance, P
机构
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
关键词
D O I
10.1158/1055-9965.EPI-14-3-EDA
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:555 / 556
页数:2
相关论文
共 15 条
[1]   Many actions of cyclooxygenase-2 in cellular dynamics and in cancer [J].
Cao, Y ;
Prescott, SM .
JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 190 (03) :279-286
[2]  
DENOON DJ, 2004, MEDSCAPE MED NEW DEC
[3]   Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis [J].
Derry, S ;
Loke, YK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7270) :1183-+
[4]   COX-2-derived prostacyclin confers atheroprotection on female mice [J].
Egan, KM ;
Lawson, JA ;
Fries, S ;
Koller, B ;
Rader, DJ ;
Smyth, EM ;
FitzGerald, GA .
SCIENCE, 2004, 306 (5703) :1954-1957
[5]  
*FDA, 2004, T0461 FDA
[6]   COX-2 and beyond: Approaches to prostaglandin inhibition in human disease [J].
FitzGerald, G .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (11) :879-890
[7]   Coxibs and cardiovascular disease [J].
FitzGerald, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) :1709-1711
[8]   Effects of a high-selenium yeast supplement on celecoxib plasma levels: A randomized Phase II trial [J].
Frank, DH ;
Roe, DJ ;
Chow, HHS ;
Guillen, JM ;
Choquette, K ;
Gracie, D ;
Francis, J ;
Fish, A ;
Alberts, DS .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (02) :299-303
[9]   The critical role of risk-benefit assessments in cancer prevention [J].
Hawk, E ;
Viner, JL .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (02) :297-298
[10]   Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the US Preventive Services Task Force [J].
Hayden, M ;
Pignone, M ;
Phillips, C ;
Mulrow, C .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (02) :161-172